Evaluation of paste formulations of fenbendazole plus piperazine against benzimidazole-resistant cyathostomes in horses.
D000818:Animals; D001562:Benzimidazoles / Q000494:pharmacology / Q000627:therapeutic use*; D004338:Drug Combinations; D004351:Drug Resistance; D005243:Feces / Q000469:parasitology; D005273:Fenbendazole / Q000627:therapeutic use*; D006736:Horses; D009015:Morantel / Q000627:therapeutic use*; D009348:Nematoda / Q000187:drug effects; D009824:Ointments; D010270:Parasite Egg Count / Q000662:veterinary; D000077489:Piperazine; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D013319:Strongyle Infections, Equine / Q000188:drug therapy*
D001562:Benzimidazoles; D004338:Drug Combinations; D009824:Ointments; D010879:Piperazines; D011743:Pyrimidines; D000077489:Piperazine; D005273:Fenbendazole; D009015:Morantel